Market and company headlines
The global cannabis use disorder market is projected to grow significantly from 2025 to 2035, driven by cannabis legalization, rising awareness, research funding and demand for effective addiction treatments. Investigational therapies include cannabinoid receptor modulators and serotonin-based drugs, such as Aelis Farma’s AEF0117 and Anebulo Pharmaceuticals’ ANEB-001. North America is expected to lead, followed by Europe, while Asia-Pacific and other regions offer emerging opportunities. Key bar
Yahoo·04:14·Last MonthANEB